Abilify News Archives

Newsroom category: Abilify News

Abilify Compulsive Behaviors Not as “Rare” as The FDA States

November 23, 2016

In May of 2016, the FDA finally issued a warning about the antidepressant medication aripiprizole, sold under the brand name Abilify as well as in generic form. That warning stated that use of aripiprizole “may” result in compulsive, uncontrollable urges to gamble, binge eat and have sex. The agency’s warning noted that while these side […]

Free Case Evalulation

Name

Email(Required)

Phone Number(Required)

Describe your legal issue

Terms for Submitting Inquiry

By clicking the "I agree" and "Submit for Free Evaluation" buttons, I agree to the POLICIES AND DISCLAIMERS, including arbitration provision therein, and consent to receive marketing emails, calls and/or texts, including those made using an automated system and/or artificial/prerecorded voice messages, from or on behalf of Levin Papantonio regarding their services in response to my inquiry at the telephone number(s) provided above, even if currently listed on any state, federal or corporate Do Not Call registry. I understand my consent to receive automated marketing calls/texts is not required as a condition of purchasing any services. However, if I do not consent, then I must call the law firm directly at 800-277-1193 in order to obtain services. I can revoke my consent at any time.

Untitled(Required)

I Agree

Name

This field is for validation purposes and should be left unchanged.